首页 > 最新文献

Clinical Nuclear Medicine最新文献

英文 中文
131 I Accumulation Due to an Intrauterine Device in a Papillary Thyroid Carcinoma Patient. 甲状腺乳头状癌患者宫内装置导致的 131I 积累。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-01 Epub Date: 2024-11-27 DOI: 10.1097/RLU.0000000000005597
Yuan Feng, Xiaoli Lan, Xiao Zhang

Abstract: A 46-year-old woman underwent 131 I radiotherapy following thyroidectomy for papillary thyroid carcinoma. Posttherapeutic 131 I scintigraphy was performed 4 days later. Both attenuation-corrected and non-attenuation-corrected 131 I tomography images elucidated an intrauterine device with avid 131 I uptake in her uterus. This case illustrated that an intrauterine device should be considered as a potential cause of false-positive results in posttherapeutic 131 I scintigraphy, highlighting the need for accurate image interpretation to avoid unnecessary treatment.

摘要:一名 46 岁的女性因甲状腺乳头状癌接受甲状腺切除术后,接受了 131I 放射治疗。4 天后进行了治疗后 131I 闪烁扫描。经衰减校正和非衰减校正的 131I 层析成像均显示,她的子宫内有一个宫内装置,并伴有狂热的 131I 摄取。该病例表明,宫内装置应被视为治疗后 131I 闪烁层造影出现假阳性结果的潜在原因,这也强调了准确解读图像以避免不必要治疗的必要性。
{"title":"131 I Accumulation Due to an Intrauterine Device in a Papillary Thyroid Carcinoma Patient.","authors":"Yuan Feng, Xiaoli Lan, Xiao Zhang","doi":"10.1097/RLU.0000000000005597","DOIUrl":"10.1097/RLU.0000000000005597","url":null,"abstract":"<p><strong>Abstract: </strong>A 46-year-old woman underwent 131 I radiotherapy following thyroidectomy for papillary thyroid carcinoma. Posttherapeutic 131 I scintigraphy was performed 4 days later. Both attenuation-corrected and non-attenuation-corrected 131 I tomography images elucidated an intrauterine device with avid 131 I uptake in her uterus. This case illustrated that an intrauterine device should be considered as a potential cause of false-positive results in posttherapeutic 131 I scintigraphy, highlighting the need for accurate image interpretation to avoid unnecessary treatment.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"341-342"},"PeriodicalIF":9.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142726261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous T-Cell Lymphoma Masquerading as Leishmaniasis Via 18 F-FDG PET/CT. 通过18F-FDG PET/CT伪装成利什曼病的皮肤t细胞淋巴瘤。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-01 Epub Date: 2024-12-18 DOI: 10.1097/RLU.0000000000005643
Prakash Singh, Yogita Khandelwal, Vineet Mishra, Shiwangi Yadav

Abstract: Cutaneous T-cell lymphomas (CTCLs) characterized by infiltration of the skin of T-cell lymphocytes represent an uncommon and rare subset of extranodal non-Hodgkin lymphomas. Primary CTCL, not otherwise specified, is among the most important subtypes of CTCLs characterized by rapid cutaneous dissemination and systemic involvement. Herein, we present a case of primary CTCL, not otherwise specified, diagnosed via 18 F-FDG PET/CT after initial misdiagnosis of cutaneous leishmaniasis.

摘要:皮肤t细胞淋巴瘤(CTCLs)以皮肤t细胞淋巴细胞浸润为特征,是结外非霍奇金淋巴瘤中一种罕见的亚型。原发性CTCL是CTCL中最重要的亚型之一,其特征是快速皮肤扩散和全身受累。在此,我们报告一例原发性CTCL,未另行说明,在最初误诊皮肤利什曼病后,通过18F-FDG PET/CT诊断。
{"title":"Cutaneous T-Cell Lymphoma Masquerading as Leishmaniasis Via 18 F-FDG PET/CT.","authors":"Prakash Singh, Yogita Khandelwal, Vineet Mishra, Shiwangi Yadav","doi":"10.1097/RLU.0000000000005643","DOIUrl":"10.1097/RLU.0000000000005643","url":null,"abstract":"<p><strong>Abstract: </strong>Cutaneous T-cell lymphomas (CTCLs) characterized by infiltration of the skin of T-cell lymphocytes represent an uncommon and rare subset of extranodal non-Hodgkin lymphomas. Primary CTCL, not otherwise specified, is among the most important subtypes of CTCLs characterized by rapid cutaneous dissemination and systemic involvement. Herein, we present a case of primary CTCL, not otherwise specified, diagnosed via 18 F-FDG PET/CT after initial misdiagnosis of cutaneous leishmaniasis.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"e218-e219"},"PeriodicalIF":9.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Superscan in First Posttherapeutic 177 Lu-PSMA Scan. 第一次治疗后177Lu-PSMA扫描的超扫描。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-01 Epub Date: 2024-12-03 DOI: 10.1097/RLU.0000000000005624
Merve Nida Calderon Tobar, Farise Yilmaz, Lütfü Perktaş

Abstract: This case highlights the effectiveness of 177 Lu-PSMA therapy in a 70-year-old man with castration-resistant prostate cancer who has extensive skeletal metastases in posttherapeutic whole-body imaging. A 70-year-old man with extensive skeletal metastases underwent 4 cycles of 177 Lu-PSMA-617 therapy. A whole-body 177 Lu-PSMA scan after the first cycle showed diffuse skeletal lesions, with minimal PSMA uptake in the kidneys and salivary glands. A whole-body scan after the fourth cycle of 177 Lu-PSMA showed a complete response of skeletal metastases with normal PSMA uptake in the kidneys and salivary glands. According to RECİP 1.0, the patient was considered a complete response.

摘要:本病例强调了177Lu-PSMA治疗在70岁男性去势抵抗性前列腺癌患者治疗后全身成像中广泛骨骼转移的有效性。一例70岁男性广泛骨骼转移患者接受了4个周期的177 Lu-PSMA-617治疗。第一个周期后的全身177Lu-PSMA扫描显示弥漫性骨骼病变,肾脏和唾液腺中PSMA摄取极少。第四个周期177Lu-PSMA后的全身扫描显示骨骼转移完全缓解,肾脏和唾液腺的PSMA摄取正常。根据RECİP 1.0,认为患者完全缓解。
{"title":"Superscan in First Posttherapeutic 177 Lu-PSMA Scan.","authors":"Merve Nida Calderon Tobar, Farise Yilmaz, Lütfü Perktaş","doi":"10.1097/RLU.0000000000005624","DOIUrl":"10.1097/RLU.0000000000005624","url":null,"abstract":"<p><strong>Abstract: </strong>This case highlights the effectiveness of 177 Lu-PSMA therapy in a 70-year-old man with castration-resistant prostate cancer who has extensive skeletal metastases in posttherapeutic whole-body imaging. A 70-year-old man with extensive skeletal metastases underwent 4 cycles of 177 Lu-PSMA-617 therapy. A whole-body 177 Lu-PSMA scan after the first cycle showed diffuse skeletal lesions, with minimal PSMA uptake in the kidneys and salivary glands. A whole-body scan after the fourth cycle of 177 Lu-PSMA showed a complete response of skeletal metastases with normal PSMA uptake in the kidneys and salivary glands. According to RECİP 1.0, the patient was considered a complete response.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"e248-e249"},"PeriodicalIF":9.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142767014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What's the Gut Doing in the Chest? Interpositio Hepatodiaphragmatica (Chilaiditi Sign) Revisited on 18 F-FDG PET/CT. 肠道在胸腔里做什么?18F-FDG PET/CT复查肝膈间置(Chilaiditi征象)。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-01 Epub Date: 2025-01-09 DOI: 10.1097/RLU.0000000000005653
Abhay Gondhane, Gaurav Malhotra

Abstract: A 47-year-old woman, a diagnosed case of syndrome of inappropriate secretion of antidiuretic hormone, underwent 18 F-FDG PET/CT to detect occult malignancy for suspected paraneoplastic etiology. Abnormal FDG uptake was noted in the right lower chest region, which was correlated on corresponding CT images to be colonic activity interposed between the liver and elevated diaphragm, also known as Chilaiditi sign. Even though rare, Chilaiditi sign should be considered as a differential diagnosis of hypermetabolic activity in the right lower chest region on 18 F-FDG PET/CT scan that is done to look for occult tumor as shown in this case.

摘要1例47岁女性,诊断为抗利尿激素分泌异常综合征,行18F-FDG PET/CT检查隐匿性恶性肿瘤,疑似副肿瘤病因。右下胸区域FDG摄取异常,相应CT图像与肝脏和膈肌升高之间的结肠活动相关,也称为Chilaiditi征象。尽管罕见,但如本例所示,在18F-FDG PET/CT扫描中,Chilaiditi征象应被视为右下胸区域高代谢活动的鉴别诊断。
{"title":"What's the Gut Doing in the Chest? Interpositio Hepatodiaphragmatica (Chilaiditi Sign) Revisited on 18 F-FDG PET/CT.","authors":"Abhay Gondhane, Gaurav Malhotra","doi":"10.1097/RLU.0000000000005653","DOIUrl":"10.1097/RLU.0000000000005653","url":null,"abstract":"<p><strong>Abstract: </strong>A 47-year-old woman, a diagnosed case of syndrome of inappropriate secretion of antidiuretic hormone, underwent 18 F-FDG PET/CT to detect occult malignancy for suspected paraneoplastic etiology. Abnormal FDG uptake was noted in the right lower chest region, which was correlated on corresponding CT images to be colonic activity interposed between the liver and elevated diaphragm, also known as Chilaiditi sign. Even though rare, Chilaiditi sign should be considered as a differential diagnosis of hypermetabolic activity in the right lower chest region on 18 F-FDG PET/CT scan that is done to look for occult tumor as shown in this case.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"e250-e252"},"PeriodicalIF":9.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142946130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Negative 18 F-FDG and Positive 68 Ga-FAPI-04 Findings in a Patient With Acute Exacerbation of Chronic Cholecystitis. 一名慢性胆囊炎急性加重患者的 18F-FDG 阴性和 68Ga-FAPI-04 阳性结果。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-01 Epub Date: 2024-10-14 DOI: 10.1097/RLU.0000000000005504
Na Qi, Jie Ding, Haiyan Wang, Jun Zhao

Abstract: Acute cholecystitis typically exhibits intense FDG uptake of the gallbladder wall. Radiolabeled fibroblast activation protein inhibitor (FAPI) is considered as a potential alternative agent for tumor-specific imaging. We report 18 F-FDG and 68 Ga-FAPI-04 PET/MR findings in a 44-year-old woman with acute exacerbation of chronic cholecystitis. The lesions show negative 18 F-FDG uptake but intense 68 Ga-FAPI-04 uptake in PET/MR. This case highlights the imperative for nuclear medicine clinicians to exercise vigilance when evaluating gallbladder lesions exhibiting intense 68 Ga-FAPI-04 but negative 18 F-FDG uptake.

摘要:急性胆囊炎通常会在胆囊壁上表现出强烈的 FDG 摄取。放射性标记的成纤维细胞活化蛋白抑制剂(FAPI)被认为是肿瘤特异性成像的潜在替代药物。我们报告了一名患有慢性胆囊炎急性加重的 44 岁女性的 18F-FDG 和 68Ga-FAPI-04 PET/MR 结果。病变显示 18F-FDG 摄取阴性,但在 PET/MR 中 68Ga-FAPI-04 摄取强烈。本病例强调了核医学临床医生在评估表现出强 68Ga-FAPI-04 摄取但 18F-FDG 摄取阴性的胆囊病变时必须保持警惕。
{"title":"Negative 18 F-FDG and Positive 68 Ga-FAPI-04 Findings in a Patient With Acute Exacerbation of Chronic Cholecystitis.","authors":"Na Qi, Jie Ding, Haiyan Wang, Jun Zhao","doi":"10.1097/RLU.0000000000005504","DOIUrl":"10.1097/RLU.0000000000005504","url":null,"abstract":"<p><strong>Abstract: </strong>Acute cholecystitis typically exhibits intense FDG uptake of the gallbladder wall. Radiolabeled fibroblast activation protein inhibitor (FAPI) is considered as a potential alternative agent for tumor-specific imaging. We report 18 F-FDG and 68 Ga-FAPI-04 PET/MR findings in a 44-year-old woman with acute exacerbation of chronic cholecystitis. The lesions show negative 18 F-FDG uptake but intense 68 Ga-FAPI-04 uptake in PET/MR. This case highlights the imperative for nuclear medicine clinicians to exercise vigilance when evaluating gallbladder lesions exhibiting intense 68 Ga-FAPI-04 but negative 18 F-FDG uptake.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"349-351"},"PeriodicalIF":9.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142459918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metastatic Prostate Carcinoma to the Ankle Seen on Bone Scintigraphy and Extended Field-of-View PSMA PET/CT. 骨显像和扩展视野PSMA PET/CT显示转移性前列腺癌至踝关节。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-01 Epub Date: 2024-12-03 DOI: 10.1097/RLU.0000000000005616
Nir Hod, Noa Shani Shrem, Daniel Levin

Abstract: We describe a rare case of metastatic prostate carcinoma to the heel. Bone scintigraphy revealed high uptake simulating fractures. Standard PSMA PET/CT was negative. As PSA elevated, extended field-of-view PET/CT revealed ankle uptake with virtually identical spatial distribution and intensity of both tracers. Histopathology confirmed ankle metastases of prostate carcinoma, which retrospectively was the inaugural manifestation of the metastatic skeletal disease. This case highlights the need to consider peripheral limb bone metastases in patients with biochemical recurrence. In case of focal symptoms or unexplained bone scan findings, the PSMA acquisition coverage should be extended to include the respective body part.

摘要:我们报告一例罕见的前列腺癌转移至足跟。骨显像显示高摄取模拟骨折。标准PSMA PET/CT阴性。当PSA升高时,扩展视场PET/CT显示两种示踪剂的空间分布和强度几乎相同。组织病理学证实踝关节前列腺癌转移,这是回顾性转移性骨骼疾病的首次表现。本病例强调了生化复发患者需要考虑外周肢体骨转移。在局灶性症状或不明原因的骨扫描结果的情况下,PSMA采集的覆盖范围应扩大到包括相应的身体部位。
{"title":"Metastatic Prostate Carcinoma to the Ankle Seen on Bone Scintigraphy and Extended Field-of-View PSMA PET/CT.","authors":"Nir Hod, Noa Shani Shrem, Daniel Levin","doi":"10.1097/RLU.0000000000005616","DOIUrl":"10.1097/RLU.0000000000005616","url":null,"abstract":"<p><strong>Abstract: </strong>We describe a rare case of metastatic prostate carcinoma to the heel. Bone scintigraphy revealed high uptake simulating fractures. Standard PSMA PET/CT was negative. As PSA elevated, extended field-of-view PET/CT revealed ankle uptake with virtually identical spatial distribution and intensity of both tracers. Histopathology confirmed ankle metastases of prostate carcinoma, which retrospectively was the inaugural manifestation of the metastatic skeletal disease. This case highlights the need to consider peripheral limb bone metastases in patients with biochemical recurrence. In case of focal symptoms or unexplained bone scan findings, the PSMA acquisition coverage should be extended to include the respective body part.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"e241-e244"},"PeriodicalIF":9.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142766970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of 99m Tc-FAPI-46 Imaging in a Patient With Medullary Thyroid Carcinoma : Navigating the Landscape of Novel Radiotracers. 99mTc-FAPI-46成像在甲状腺髓样癌患者中的应用:导航新型放射性示踪剂的前景。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-01 Epub Date: 2024-12-31 DOI: 10.1097/RLU.0000000000005605
Nasrin Raeisi, Amin Saber Tanha, Somayeh Barashki, Navid Nateghi, Kamran Aryana

Abstract: We present the case of a 58-year-old man with metastatic medullary thyroid carcinoma refractory to conventional therapies, including peptide receptor radionuclide therapy. Despite multiple interventions, serum calcitonin and carcinoembryonic antigen levels continued to rise. Subsequent evaluation with 99m Tc-FAPI-46 revealed remarkable uptake in metastatic lesions, suggesting a potential role for FAPI-labeled radioisotopes in the management of medullary thyroid carcinoma. This case underscores the emerging utility of FAPI-targeted radiotracers in oncologic nuclear medicine and highlights the need for further research in this promising area.

摘要:我们报告一例58岁男性转移性甲状腺髓样癌,常规治疗包括肽受体放射性核素治疗无效。尽管多次干预,血清降钙素和癌胚抗原水平继续上升。随后99mTc-FAPI-46的评估显示转移灶中有明显的摄取,表明fapi标记的放射性同位素在甲状腺髓样癌的治疗中具有潜在的作用。该病例强调了fapi靶向放射性示踪剂在肿瘤核医学中的新兴应用,并强调了在这一有前途的领域进一步研究的必要性。
{"title":"Application of 99m Tc-FAPI-46 Imaging in a Patient With Medullary Thyroid Carcinoma : Navigating the Landscape of Novel Radiotracers.","authors":"Nasrin Raeisi, Amin Saber Tanha, Somayeh Barashki, Navid Nateghi, Kamran Aryana","doi":"10.1097/RLU.0000000000005605","DOIUrl":"10.1097/RLU.0000000000005605","url":null,"abstract":"<p><strong>Abstract: </strong>We present the case of a 58-year-old man with metastatic medullary thyroid carcinoma refractory to conventional therapies, including peptide receptor radionuclide therapy. Despite multiple interventions, serum calcitonin and carcinoembryonic antigen levels continued to rise. Subsequent evaluation with 99m Tc-FAPI-46 revealed remarkable uptake in metastatic lesions, suggesting a potential role for FAPI-labeled radioisotopes in the management of medullary thyroid carcinoma. This case underscores the emerging utility of FAPI-targeted radiotracers in oncologic nuclear medicine and highlights the need for further research in this promising area.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"e209-e210"},"PeriodicalIF":9.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142945875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Central Nervous System Tumor-Embryonal Tumors Type With Neuroendocrine Differentiation. 中枢神经系统肿瘤-胚胎肿瘤类型与神经内分泌分化。
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-01 Epub Date: 2024-12-30 DOI: 10.1097/RLU.0000000000005655
Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu

Abstract: The central nervous system (CNS) tumor with embryonal tumors type is a rare type of CNS tumor with lack of unifying genetic alterations or diagnostic markers. The CNS tumor-embryonal tumors (CETs) have limited therapeutic options with high probability of adverse events associated with conventional treatment. Identification of somatostatin receptor expression and/or prostate-specific membrane antigen expression in CET patients by using PET/CT imaging may be helpful for deciding therapeutic approaches in these patients as theranostics. We present a 56-year-old woman who complained of headache, diminution of vision, and diagnosed CET and demonstrated high SSTR expression on PET/CT imaging, indicating peptide receptor radionuclide therapy could be effective therapeutic option in this case.

摘要:胚胎型中枢神经系统(CNS)肿瘤是一种罕见的中枢神经系统肿瘤,缺乏统一的遗传改变或诊断标记。中枢神经系统肿瘤-胚胎性肿瘤(cts)的治疗选择有限,与常规治疗相关的不良事件的概率很高。利用PET/CT成像技术鉴定CET患者的生长抑素受体表达和/或前列腺特异性膜抗原表达可能有助于确定这些患者的治疗方法。我们报告了一位56岁的女性,主诉头痛,视力下降,诊断为CET, PET/CT显示高SSTR表达,提示肽受体放射性核素治疗可能是这种情况下有效的治疗选择。
{"title":"Central Nervous System Tumor-Embryonal Tumors Type With Neuroendocrine Differentiation.","authors":"Yeshwanth Edamadaka, Rahul V Parghane, Sandip Basu","doi":"10.1097/RLU.0000000000005655","DOIUrl":"10.1097/RLU.0000000000005655","url":null,"abstract":"<p><strong>Abstract: </strong>The central nervous system (CNS) tumor with embryonal tumors type is a rare type of CNS tumor with lack of unifying genetic alterations or diagnostic markers. The CNS tumor-embryonal tumors (CETs) have limited therapeutic options with high probability of adverse events associated with conventional treatment. Identification of somatostatin receptor expression and/or prostate-specific membrane antigen expression in CET patients by using PET/CT imaging may be helpful for deciding therapeutic approaches in these patients as theranostics. We present a 56-year-old woman who complained of headache, diminution of vision, and diagnosed CET and demonstrated high SSTR expression on PET/CT imaging, indicating peptide receptor radionuclide therapy could be effective therapeutic option in this case.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"e238-e240"},"PeriodicalIF":9.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142946008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radio-Guided Monitoring of Systemic Leakage With 99m Tc-MAA Uptake in a Patient With Melanoma During Isolated Limb Perfusion.
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-01 Epub Date: 2025-02-20 DOI: 10.1097/RLU.0000000000005612
Mohammad Hadi Samadi, Ehsan Hasanzadeh Hadad, Susan Khezri, Ramin Sadeghi, Atena Aghaee

Abstract: We present a case of a 65-year-old woman with a history of melanoma of the left foot who underwent tumor resection with inguinal lymph nodes dissection and received external beam radiation therapy. After some time, she developed nodular lesions in the same region that were confirmed to be due to involvement of the dermis. She was selected as a candidate for isolated limb perfusion procedure. The isolated limb perfusion was performed with the aid of radioguided monitoring of systemic leakage by injecting 99m Tc-labeled macroaggregated albumin, and whole-body acquisition was also performed, which confirmed compartmental localization of the tracer. Our case is the first one in which 99m Tc-labeled macroaggregated albumin injection has been used.

{"title":"Radio-Guided Monitoring of Systemic Leakage With 99m Tc-MAA Uptake in a Patient With Melanoma During Isolated Limb Perfusion.","authors":"Mohammad Hadi Samadi, Ehsan Hasanzadeh Hadad, Susan Khezri, Ramin Sadeghi, Atena Aghaee","doi":"10.1097/RLU.0000000000005612","DOIUrl":"10.1097/RLU.0000000000005612","url":null,"abstract":"<p><strong>Abstract: </strong>We present a case of a 65-year-old woman with a history of melanoma of the left foot who underwent tumor resection with inguinal lymph nodes dissection and received external beam radiation therapy. After some time, she developed nodular lesions in the same region that were confirmed to be due to involvement of the dermis. She was selected as a candidate for isolated limb perfusion procedure. The isolated limb perfusion was performed with the aid of radioguided monitoring of systemic leakage by injecting 99m Tc-labeled macroaggregated albumin, and whole-body acquisition was also performed, which confirmed compartmental localization of the tracer. Our case is the first one in which 99m Tc-labeled macroaggregated albumin injection has been used.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"e220-e222"},"PeriodicalIF":9.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143467126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pineal Gland Activity in Advanced-Stage Pediatric Neuroblastoma Patients on 68 Ga-DOTATATE PET/CT. 68Ga-DOTATATE PET/CT对晚期小儿神经母细胞瘤患者松果体活性的影响
IF 9.6 3区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-04-01 Epub Date: 2024-12-13 DOI: 10.1097/RLU.0000000000005626
Emine Goknur Isik, Dilara Denizmen, Dilşad Fırat Arslan, Duygu Has Simsek, Zeynep Gözde Özkan

Abstract: Neuroblastoma is the most common malignancy in infants and the most common extracranial solid tumor accounting for approximately 6% of pediatric cancer. Although surgical intervention serves as the primary treatment for early-stage disease, advanced-stage cases necessitate a variety of oncologic therapeutic approaches, including 131 I-MIBG and peptide receptor radionuclide therapy. Herein we report incidental pineal gland activity, represented in 68 Ga-DOTATATE PET/CT (SSTR-PET) in 3 pediatric patients diagnosed with stage 4 neuroblastoma, related to the physiological distribution of radiopharmaceuticals.

摘要:神经母细胞瘤是婴儿最常见的恶性肿瘤,也是最常见的颅外实体瘤,约占儿科癌症的6%。虽然手术治疗是早期疾病的主要治疗方法,但晚期病例需要采用多种肿瘤治疗方法,包括 131I-MIBG 和肽受体放射性核素治疗。在此,我们报告了在 3 名确诊为神经母细胞瘤 4 期的儿科患者中,68Ga-DOTATATE PET/CT(SSTR-PET)显示的松果体活动,这与放射性药物的生理分布有关。
{"title":"Pineal Gland Activity in Advanced-Stage Pediatric Neuroblastoma Patients on 68 Ga-DOTATATE PET/CT.","authors":"Emine Goknur Isik, Dilara Denizmen, Dilşad Fırat Arslan, Duygu Has Simsek, Zeynep Gözde Özkan","doi":"10.1097/RLU.0000000000005626","DOIUrl":"10.1097/RLU.0000000000005626","url":null,"abstract":"<p><strong>Abstract: </strong>Neuroblastoma is the most common malignancy in infants and the most common extracranial solid tumor accounting for approximately 6% of pediatric cancer. Although surgical intervention serves as the primary treatment for early-stage disease, advanced-stage cases necessitate a variety of oncologic therapeutic approaches, including 131 I-MIBG and peptide receptor radionuclide therapy. Herein we report incidental pineal gland activity, represented in 68 Ga-DOTATATE PET/CT (SSTR-PET) in 3 pediatric patients diagnosed with stage 4 neuroblastoma, related to the physiological distribution of radiopharmaceuticals.</p>","PeriodicalId":10692,"journal":{"name":"Clinical Nuclear Medicine","volume":" ","pages":"343-345"},"PeriodicalIF":9.6,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142817345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Nuclear Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1